News

Crinetics Pharmaceuticals Expands Employee Stock Option Grants

Crinetics Pharmaceuticals Expands Employee Stock Option Grants

Crinetics Pharmaceuticals Announces Stock Option Grants

SAN DIEGO, December 10, 2025 - Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) is shaping its workforce dynamics by announcing the granting of non-qualified stock options and restricted stock units (RSUs) to new employees. A total of 39,575 shares were awarded, along with 26,525 RSUs, under the company’s 2021 Employment Inducement Incentive Award Plan.

Understanding the 2021 Inducement Plan

The 2021 Inducement Plan serves as a strategic tool for Crinetics, exclusively designed to attract talent who have not previously worked with the company. This plan allows for equity awards tailored for individuals starting employment after a substantial break, adhering to Nasdaq Listing Rule 5635(c)(4). The stock options provided have an exercise price set at $48.06, matching the closing price of Crinetics’ common stock on this notable date.

The stock options are structured to vest over four years, with a quarter of the shares becoming available after the first year and the remaining shares vesting monthly. Similarly, RSUs are slated to vest in equal annual increments starting a year after employment begins, fostering long-term commitment among the new hires. The vesting schedules for both types of awards are contingent upon continued employment at Crinetics.

Crinetics’ Commitment to Employee Growth

This initiative underscores Crinetics Pharmaceuticals’ commitment not just to its mission of developing treatments for endocrine diseases, but also to nurturing its team. By offering stock options, the company promotes a culture of ownership, empowering employees to contribute actively to the company’s success. This approach aligns personal achievements with corporate objectives, creating a motivated workforce poised for innovation.

The Vision of Crinetics Pharmaceuticals

Crinetics Pharmaceuticals is dedicated to revolutionizing the landscape of endocrine disease therapy. Focusing on the development of innovative therapies, the company targets G-protein coupled receptors (GPCRs) with specialized small molecules, intent on addressing critical patient needs.

The hallmark product of Crinetics, PALSONIFY™ (paltusotine), is groundbreaking as the first oral treatment approved for patients with acromegaly who have not benefitted sufficiently from surgery. Beyond acromegaly, Crinetics is exploring paltusotine's efficacy in treating carcinoid syndrome linked to neuroendocrine tumors.

Diverse Development Pipeline

Crinetics boasts a comprehensive pipeline with over ten programs in various stages of investigation. Among these, atumelnant is notably advancing through late-stage clinical trials focusing on congenital adrenal hyperplasia and ACTH-dependent Cushing’s syndrome. Additionally, Crinetics is undertaking research on diverse endocrine disorders, including neuroendocrine tumors, Graves’ disease, polycystic kidney disease, and diabetes, showcasing a robust commitment to addressing multiple health challenges.

Engaging with Investors and the Media

For inquiries regarding investor relations, Gayathri Diwakar serves as the dedicated Head of Investor Relations at Crinetics Pharmaceuticals. She is reachable at gdiwakar@crinetics.com or by phone at (858) 345-6340.

In terms of media relations, Natalie Badillo heads Corporate Communications. She can be contacted at nbadillo@crinetics.com or by calling (858) 450-6464. This open line of communication not only demonstrates transparency but also reflects the company’s mission to engage meaningfully with all stakeholders.

Frequently Asked Questions

What is the purpose of the stock options granted by Crinetics?

The stock options aim to attract new employees and incentivize their contributions to the company's growth.

How does the 2021 Inducement Plan work?

This plan allows Crinetics to provide equity awards to non-employees or those returning after a break, enhancing recruitment efforts.

What are the key products developed by Crinetics Pharmaceuticals?

PALSONIFY™ is Crinetics' leading product, providing treatment for acromegaly, with further developments targeting various endocrine disorders.

How long do the stock options take to vest?

The stock options vest over four years, beginning with a quarter of the shares available after the first year.

Who can be contacted for investor inquiries at Crinetics?

Gayathri Diwakar oversees investor relations and is available for any related questions or discussions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Visual Cipher Bench Exposes AI Agents' Hidden Rule Gap

Updated Category News Views 0

Forty little black-and-white puzzles just threw a bucket of cold water on the autonomous-agent sales pitch. Einsia AI’s Navers Lab says its new Visual Cipher Bench found that the best result among eight frontier models was only 26.7%, with no tested configuration clearing 30%. That is not a minor blemish. It is a reminder that a model can sound clever, use tools, and...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 105

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 222

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading
Universal Haptics Protocol May Cut Integration Friction

Updated Category News Views 301

A controller rumbling at the wrong moment is a small annoyance, but the plumbing behind that rumble has been a stubborn mess for years. The Haptics Industry Forum's Universal Haptics Protocol 1.0, announced November 17, 2026, is an attempt to clean up that mess with a shared language between software and touch-feedback hardware. This is not the sort of release that sends...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 139

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 131

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading
LG Channels UAE Push Tests the Free Streaming Model

Updated Category News Views 11

A television's idle screen is turning into contested real estate in the UAE. LG Channels is adding programming from Rakuten TV, Stingray and Red Bull TV to its free, ad-supported service, and that matters for more than somebody hunting a movie after dinner. This is a practical push to make webOS-powered screens more useful, more frequently used and, eventually, more...

Continue Reading
Trilith Holiday Tour Blends Film Access and Giving

Updated Category News Views 53

Snow machines, trolley rides, and a mental-health subsidy are sharing the same stage in Fayetteville this holiday season. That is an unusual mix, but it fits Trilith Foundation’s stated mission better than another generic lights-and-cocoa event ever could. From Nov. 21 through Dec. 31, the Foundation is turning its guided Trilith Studios tour into a seasonal experience...

Continue Reading
Holiday Grease Advice Shows Utility Work Up Close Today

Updated Category News Views 117

Butter and pan drippings are mundane right until they become a backed-up kitchen line on a crowded holiday afternoon. New Jersey American Water's Nov. 17, 2026 reminder is not glamorous utility news, and frankly it is not trying to be. It is a practical warning: fats, oils and grease can cool, harden and accumulate in household pipes and farther along the wastewater...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 49

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading

Top 5 Most Recently Viewed Articles

FlexShopper Partners with PayPossible to Enhance Payment Solutions

Updated Category News Views 152

FlexShopper Enhances Consumer Payment Solutions FlexShopper Inc., a leading name in lease-to-own (LTO) retail and payment solutions, is thrilled to share the news of its strategic partnership with PayPossible. This collaboration focuses on expanding flexible financing options for consumers through the integration of FlexShopper’s services into PayPossible’s renowned...

Continue Reading
SanDisk Set to Thrive Amid Rising AI Demand and Supply Gaps

Updated Category News Views 356

SanDisk Corporation and the Promise of AI Demand SanDisk Corporation (NASDAQ: SNDK) is experiencing a wave of investor optimism as shares surged recently. This positive sentiment primarily stems from the anticipated growth in the NAND flash memory market, driven by increasing demand from AI data centers and limited supply conditions. Market Dynamics and Future Performance...

Continue Reading
Exciting Preparations for FIFA World Cup 26 in Miami

Updated Category News Views 437

Countdown to FIFA World Cup 26 in Miami Greater Miami and Miami Beach: A Hub for Global Sports As we approach a thrilling year leading up to the FIFA World Cup 26™, anticipation builds across Greater Miami. Miami is set to solidify its status as a global sports capital, ready to host seven electrifying matches at the Hard Rock Stadium. The preparations are underway for...

Continue Reading
JKB and IFC's Bold Green Bond Move Spurs Finance

Updated Category News Views 22

Amman Sets the Stage for Green Finance Watch out, folks! Jordan Kuwait Bank (JKB), teaming up with the International Finance Corporation (IFC), is stirring the pot in Amman with its second Green Bond. This is no small fry—it’s a big-time financial ballet with a USD 100 million investment aimed squarely at reshaping the landscape of sustainable finance in Jordan....

Continue Reading
Discover Modern Living at Modera St. Paul in Dallas

Updated Category News Views 194

Modera St. Paul Opens Doors to New Residents Mill Creek Residential has recently welcomed its first residents to Modera St. Paul, a striking mixed-use community positioned in the heart of Dallas. This development adds a total of 333 homes alongside street-level retail space, creating a vibrant urban living experience. A Prime Location for Modern Living Situated at a key...

Continue Reading